Search

Researchers at the University of Pennsylvania School of Engineering have developed a method to modify lipid nanoparticles (LNPs) to target specific cells, including neurons, and cross the blood-brain barrier. This advancement could lead to potential treatments for neurological diseases like Alzheimer's and Parkinson's. By using peptides as targeting molecules, the LNPs can deliver mRNA to the brain's endothelial cells and neurons, a crucial step in developing mRNA-based treatments for brain diseases. The study was supported by various organizations, including the U.S. National Institutes of Health and the American Cancer Society. [Extracted from the article]

Researchers at Bangladesh University of Engineering and Technology (BUET) have conducted a study on vaccine development, focusing on the glycopeptide PV-PS A1 immunogen. The study found that this immunogen can elicit both CD4+ and CD8+ immune responses, making it a promising carrier for vaccine development. This research, funded by the National Institutes of Health, sheds light on the potential of PV-PS A1 as a robust MHCI- and MHCII-dependent carrier for future vaccine development. [Extracted from the article]

A recent report from Knowledge University discusses the epidemiology of Staphylococcus aureus non-susceptible to vancomycin in Western Asia. The emergence of vancomycin non-susceptible strains poses a significant challenge in controlling infections caused by this pathogen. The research focuses on understanding the mechanisms and characteristics of these strains to aid in the development of effective surveillance and control programs. For more information, the full article can be accessed through the Zanco Journal of Pure and Applied Sciences. [Extracted from the article]

Researchers at K.N. Toosi University of Technology have developed a new evidence-based design-of-experiments approach to optimize drug delivery systems for glycopeptide antibiotics. The study focuses on ensuring that drug release aligns with the therapeutic window of the medication, with a specific example of emulsion-derived Vancomycin-loaded capsules for treating Staphylococcus Aureus-induced osteomyelitis. The research findings suggest that this approach could be applicable to various delivery systems with reliable data in the literature, offering a novel and validated method for drug optimization. [Extracted from the article]

A recent study conducted by researchers at the Medical University of Gdansk in Poland highlights the potential of metabolomics in identifying biomarkers associated with obesity and its related complications, such as type 2 diabetes, cardiovascular disease, and metabolic fatty liver disease. The study focused on the influence of branched-chain amino acids, amino acids, and adipokines on the development of these conditions across different age groups and demographics. The research emphasizes the need for new diagnostic markers for early detection and intervention in obesity-related diseases, suggesting the development of biochemical test panels combining metabolites with classical markers as a way forward. [Extracted from the article]